The respected financial site, Bloomberg Businessweek, Â hasÂ released an extremely positive article on the study of Â hallucinations. The article features Heffter Board members Dr. Dave Nichols, Dr. Roland Griffiths, Dr. Charles Grob, and Dr. Stephen Ross. The Heffter Research Institute is also prominently mentioned as the source of Â funding for “… 70 studies in research journals since 1999.” To enjoy the full article please follow the link:
The Los Angeles Times on November 29, 2011 featured a very positive survey article on the status ofÂ hallucinogenic research and the changingÂ Â perceptions concerning these compounds in the medical community. Â As the Times states, “Hallucinogens and other street drugs are increasingly being studied for legitimate therapeutic uses, such as helping patients with post-traumatic stress disorder, addiction, chronic pain, depression and even terminal illness.” The research of Â Heffter Board members, Dr. Charles Grob and Dr. Roland Griffiths, isÂ prominentlyÂ featured including Â a wonderful photo of Dr. Grob in his perpetuallyÂ disheveledÂ office. On a side note Times writer, Â Melissa Healy, needs commending for using “hallucinogens” Â and notÂ succumbingÂ to the ever so problematic “psychedelic.” While the word isÂ appropriate, it does, regrettably, conjure the stigma that has so effectively shut down thisÂ researchÂ for thirty years.
Two notes of correction:
Dr. Roland Griffiths is not a “psychopharmacologist” but Â is Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University School of Medicine.
Dr. Michael P. Bogenschutz is not based at the University of ArizonaÂ Â in Tucson. Â Dr. Bogenschutz Â is Professor and Vice Chair for Research and Addictions in the Department of Psychiatry at Â the University of New Mexico inÂ Albuquerque.
Please follow the link for the Los Angeles Times article:
The Heffter Research Institute is honored to present its LifetimeÂ AchievementÂ Award to Dr. Stanislav Grof. The award was presented to Dr. Grof at theÂ Joshua Tree Retreat CenterÂ in Joshua Tree, California on September 23, 2011 by Heffter Board Member, Dr. Charles Grob. Dr. Grof is one of the worlds leading experts in psychedelics andÂ hallucinogens in relation toÂ psychiatry and psychology.Â
Â As he states, Â “… the potential significance of LSD and other psychedelics for psychiatry and psychology was comparable to the value the microscope has for biology or the telescope has for astronomy. My later experience with psychedelics only confirmed this initial impression. These substances function as unspecific amplifiers that increase the cathexis (energetic charge) associated with the deep unconscious contents of the psyche and make them available for conscious processing. This unique property of psychedelics makes it possible to study psychological undercurrents that govern our experiences and behaviours to a depth that cannot be matched by any other method and tool available in modern mainstream psychiatry and psychology. In addition, it offers unique opportunities for healing of emotional and psychosomatic disorders, for positive personality transformation, and consciousness evolution.”
Dr. Grof is an inspiration to generations ofÂ scientists,Â who, because of him, Â have not let this field of inquiry vanish.
The following are images of Dr. Charles Grob presenting the award and a close-up. Dr. Grof Â is on the left.
All of us at Heffter send Stan and Christina Grof our very best wishes!
Germany’s public radio and television broadcaster ARD has just presented a half hour program onÂ hallucinogens.DIE WIEDERKEHR DER MAGISCHEN PILZE HALLUZINOGENE IN DER PSYCHOTHERAPIE THE RETURN OF MAGIC MUSHROOMS
HALLUCINOGENS IN PSYCHOTHERAPY
The program is present by Arndt Reuning.
Featured in the program is Heffter board member Dr. Charles Grob’s ground breaking study on psilocybin’s efficacy in the treatment of Â anxiety and depression in terminal cancer patients. Heffter consultant and spokesperson, Mr. Norbert Litzinger, is also interviewed concerning the tragic death of his wife, Pamela Sakuda, who participated in Dr. Grob’s study and greatlyÂ benefited from it.
The program is in transcription and audio in German and can be read and Â listened to here. The transcript isÂ translatable through Google or other translation applications.Â Â Please click the following title and then click the title with the audio symbol.DIEÂ WIEDERKEHRÂ DERÂ MAGISCHENÂ PILZE
ARD is the second largest publicÂ broadcasterÂ in the world with a national and international reach. It utilizes every form of electronic communication. For more information please link to:Â http://www.ard.de/Â .
The PSILOCYBIN CANCER ANXIETY STUDY at NYU under the direction of Heffter board member Dr. Stephen Ross has launched their new web site.
They are looking for volunteers to participate in a scientific study exploring the effects of spiritual or mystical states of consciousness on anxiety and emotional distress associated with a diagnosis of advanced, recurrent, or potentially life threatening cancer.
For further information please visit:
The study was conducted by Dr. Roland Griffiths and his co-researchers at the Johns Hopkins University School of Medicine. Please read and ponder the implications of this fascinating study and its conclusions at the following link.
Dr. Griffiths is currently engaged in a Psilocybin study designed toÂ ameliorateÂ the symptoms of anxiety and depression in those facing a diagnosis of lifeÂ threatening cancer. The study is open and actively recruiting patients. For more information please follow the link.
Psilocybin research conducted by Dr. Roland Griffiths at the Johns Hopkins University School of Medicine has been featured in TIME magazine. Please follow the link.